Results May Vary: Individual results vary based on age, baseline health, adherence to treatment, dietary habits, activity level, consistency of use, genetic factors, current medications, and other personal variables
Cardiometabolic Improvements Weight loss was accompanied by clinically meaningful improvements across several cardiovascular risk markers, including reductions in: Waist circumference (mean reduction of approximately 24.1 cm at the highest dose) Non-HDL cholesterol Triglycerides Systolic blood pressure High-sensitivity C-reactive protein (hsCRP) a marker of inflammation These findings are particularly relevant for patients with obesity who also live with cardiometabolic conditions, where systemic risk reduction is as important as the weight loss itself
This can cause food and stomach acid to remain in your stomach longer, increasing the likelihood of acid reflux and heartburn
Most patients want to know exactly when they will start noticing changes in their skin tone after beginning Melanotan therapy